Fedratinib in Combination With Nivolumab

Clinical trial NCT05393674 · COMPLETED

Trial details

NCT number: NCT05393674
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2022-06-14
Primary completion: 2025-11-05
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.